Clinical Trials Directory

Trials / Completed

CompletedNCT06069921

Using Deep Learning and Radiomics to Diagnose Benign and Malignant Breast Lesions Based on Ultrasound

Ultrasound-based Deep Learning Signature and Radiomics Signature Nomogram for Diagnosis of Benign and Malignant Breast Lesions of BI-RADS Category 4 Using Intratumoral and Peritumoral Regions

Status
Completed
Phase
Study type
Observational
Enrollment
400 (actual)
Sponsor
Ma Zhe · Academic / Other
Sex
Female
Age
15 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This retrospective study aimed to create a prediction model using deep learning and radiomics features extracted from intratumoral and peritumoral regions of breast lesions in ultrasound images, to diagnose benign and malignant breast lesions with BI-RADS 4 classification. Materials and methods: Patients who visited in The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital were collected. Their general clinical features, information on preoperative ultrasound diagnosis, and postoperative pathologic data were reviewed.

Conditions

Timeline

Start date
2015-01-01
Primary completion
2022-12-30
Completion
2022-12-30
First posted
2023-10-06
Last updated
2024-06-25

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06069921. Inclusion in this directory is not an endorsement.